DoW Melanoma Research Program Survivorship Research Award

<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.</p> <p><strong>Distinctive Features:</strong></p> <p><span style="color: black;">·        </span>The application <strong><em>must </em></strong>include at least one <u style="color: blue;">melanoma consumer collaborator</u><span style="color: black;">, defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research.</span></p> <p><strong style="background-color: lightgrey;">·        Clinical trials </strong><strong><em>are </em></strong>allowed.</p> <p><br></p>